US Stock MarketDetailed Quotes

RMD ResMed

Watchlist
  • 238.750
  • -5.370-2.20%
Close Oct 1 16:00 ET
  • 242.300
  • +3.550+1.49%
Post 18:45 ET
35.08BMarket Cap34.50P/E (TTM)

ResMed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ResMed Q4 2024 Earnings Date

Currency：USDAug 1, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.21B
1.22B
+9.40M
Beat Est.
+8.18%
+9.01%
+0.77%
EPS
2.00
1.98
-0.02
Miss Est.
+27.89%
+26.92%
-0.76%
Analyst Rating
Buy

Oct 1, 2024

ResMed Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.251B--
--2025/Q1-- / 1.184B--
Aug 1, 20242024/Q41.223B / 1.214B--
--2024/Q31.197B / 1.172B--
Jan 24, 20242024/Q21.163B / 1.151B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.251B--
--2025/Q1-- / 1.184B--
Aug 1, 20242024/Q41.223B / 1.214B--
--2024/Q31.197B / 1.172B--
Jan 24, 20242024/Q21.163B / 1.151B--

Unlock Free Earnings Estimates

ResMed Earnings Reports

  • 10-K: FY2024 Annual Report

    Aug 9 15:50 ET

  • 10-Q: Q3 2024 Earnings Report

    Apr 26 15:59 ET

  • ResMed | 10-Q: Q2 2024 Earnings Report

    Jan 25 15:36 ET

  • ResMed | 10-Q: Q1 2024 Earnings Report

    Oct 26, 2023 19:38 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 1, 2024

    Buy

    • Buy

      63.64%

    • Hold

      27.27%

    • Sell

      9.09%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data